Cargando…

The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review

INTRODUCTION: Meconium ileus (MI) is one of the most common causes of intestinal obstruction in newborns. It is the earliest clinical manifestation of cystic fibrosis (CF). MI is suspected if a baby fails to pass meconium shortly after birth and develops symptoms of bowel obstruction, such as disten...

Descripción completa

Detalles Bibliográficos
Autores principales: Banjar, Hanaa, Qeretli, Raef, Ramadan, Ali, Al-Ibraheem, Abdullah, Bnatig, Fahad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: King Faisal Specialist Hospital and Research Centre 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072234/
https://www.ncbi.nlm.nih.gov/pubmed/35573065
http://dx.doi.org/10.1016/j.ijpam.2021.03.008
_version_ 1784701014630203392
author Banjar, Hanaa
Qeretli, Raef
Ramadan, Ali
Al-Ibraheem, Abdullah
Bnatig, Fahad
author_facet Banjar, Hanaa
Qeretli, Raef
Ramadan, Ali
Al-Ibraheem, Abdullah
Bnatig, Fahad
author_sort Banjar, Hanaa
collection PubMed
description INTRODUCTION: Meconium ileus (MI) is one of the most common causes of intestinal obstruction in newborns. It is the earliest clinical manifestation of cystic fibrosis (CF). MI is suspected if a baby fails to pass meconium shortly after birth and develops symptoms of bowel obstruction, such as distention of the abdomen or vomiting. MI can lead to bowel perforation, a twisting of the bowel, or inflammation and infection of the abdominal cavity. OBJECTIVES: To find the incidence and prevalence of meconium ileus in cystic fibrosis patients and to report on the most common gene mutation of MI in CF patients. METHODOLOGY: Retrospective review of the medical documentations of all MI patients during the period of 1989–2018. RESULTS: A total of 40 CF confirmed patients were presented with MI. Twenty-nine patients (71%) are alive and 11 patients (29%) died or lost to follow-up. The following CFTR mutations were found: Eight patients (20%) with c.2988+1G>A; Intron 18. Seven patients (17.5%) with c.1418delG; Exon 11. Five patients (12.5%) with c.579+1G>T; Intron 5. Four patients (10%) with c.1911delG; Exon 14. Four patients (10%) with c.1521_1523delCTT; Exon 11. Four patients (10%) with c.416A>T; Exon 13. Three patients (7.5%) with c.2421A>G; Exon 14. Two patients (5%) with c.3908A>C; Exon 21. One patient (2.5%) with c.3889dupT; Exon 24. One patient (2.5%) with c.1657C>T; Exon 12. One patient (2.5%) with c.2547C>A; Exon 14a. Eighteen patients (45%) were presented with vomiting, 38 patients (95%) had postnatal radiological findings, 7 patients (17.5%) had electrolytes imbalance. Five patients (12.5%) had cholestasis and 4 patients (10%) developed chronic liver disease. Thirty-five patients (79.5%) underwent surgical repair and 9 patients (20.5%) were treated medically. Mean age of operation was 2.25 (2) days. Of 9 patients, 6 (66.6%) were treated with gastrograffin enema, 2 patients (22.2%) with oral N-acetylcysteine and 1 patient (11.1%) with saline rectal wash. Thirteen patients (31.5%) required TPN. Five patients had recurrent operation. CONCLUSION: CF and meconium ileus are commonly present in CF patients in Saudi Arabia. Prognosis is similar to other CFs without MI, if treated early. Thirty percent of our CF/MI patients have intronic mutations.
format Online
Article
Text
id pubmed-9072234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher King Faisal Specialist Hospital and Research Centre
record_format MEDLINE/PubMed
spelling pubmed-90722342022-05-13 The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review Banjar, Hanaa Qeretli, Raef Ramadan, Ali Al-Ibraheem, Abdullah Bnatig, Fahad Int J Pediatr Adolesc Med Original Article INTRODUCTION: Meconium ileus (MI) is one of the most common causes of intestinal obstruction in newborns. It is the earliest clinical manifestation of cystic fibrosis (CF). MI is suspected if a baby fails to pass meconium shortly after birth and develops symptoms of bowel obstruction, such as distention of the abdomen or vomiting. MI can lead to bowel perforation, a twisting of the bowel, or inflammation and infection of the abdominal cavity. OBJECTIVES: To find the incidence and prevalence of meconium ileus in cystic fibrosis patients and to report on the most common gene mutation of MI in CF patients. METHODOLOGY: Retrospective review of the medical documentations of all MI patients during the period of 1989–2018. RESULTS: A total of 40 CF confirmed patients were presented with MI. Twenty-nine patients (71%) are alive and 11 patients (29%) died or lost to follow-up. The following CFTR mutations were found: Eight patients (20%) with c.2988+1G>A; Intron 18. Seven patients (17.5%) with c.1418delG; Exon 11. Five patients (12.5%) with c.579+1G>T; Intron 5. Four patients (10%) with c.1911delG; Exon 14. Four patients (10%) with c.1521_1523delCTT; Exon 11. Four patients (10%) with c.416A>T; Exon 13. Three patients (7.5%) with c.2421A>G; Exon 14. Two patients (5%) with c.3908A>C; Exon 21. One patient (2.5%) with c.3889dupT; Exon 24. One patient (2.5%) with c.1657C>T; Exon 12. One patient (2.5%) with c.2547C>A; Exon 14a. Eighteen patients (45%) were presented with vomiting, 38 patients (95%) had postnatal radiological findings, 7 patients (17.5%) had electrolytes imbalance. Five patients (12.5%) had cholestasis and 4 patients (10%) developed chronic liver disease. Thirty-five patients (79.5%) underwent surgical repair and 9 patients (20.5%) were treated medically. Mean age of operation was 2.25 (2) days. Of 9 patients, 6 (66.6%) were treated with gastrograffin enema, 2 patients (22.2%) with oral N-acetylcysteine and 1 patient (11.1%) with saline rectal wash. Thirteen patients (31.5%) required TPN. Five patients had recurrent operation. CONCLUSION: CF and meconium ileus are commonly present in CF patients in Saudi Arabia. Prognosis is similar to other CFs without MI, if treated early. Thirty percent of our CF/MI patients have intronic mutations. King Faisal Specialist Hospital and Research Centre 2022-03 2021-03-22 /pmc/articles/PMC9072234/ /pubmed/35573065 http://dx.doi.org/10.1016/j.ijpam.2021.03.008 Text en © 2021 Publishing services provided by Elsevier B.V. on behalf of King Faisal Specialist Hospital & Research Centre (General Organization), Saudi Arabia. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Article
Banjar, Hanaa
Qeretli, Raef
Ramadan, Ali
Al-Ibraheem, Abdullah
Bnatig, Fahad
The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title_full The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title_fullStr The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title_full_unstemmed The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title_short The first report on CFTR mutations of meconium ileus in cystic fibrosis population in Saudi Arabia: A single center review
title_sort first report on cftr mutations of meconium ileus in cystic fibrosis population in saudi arabia: a single center review
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072234/
https://www.ncbi.nlm.nih.gov/pubmed/35573065
http://dx.doi.org/10.1016/j.ijpam.2021.03.008
work_keys_str_mv AT banjarhanaa thefirstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT qeretliraef thefirstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT ramadanali thefirstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT alibraheemabdullah thefirstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT bnatigfahad thefirstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT banjarhanaa firstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT qeretliraef firstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT ramadanali firstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT alibraheemabdullah firstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview
AT bnatigfahad firstreportoncftrmutationsofmeconiumileusincysticfibrosispopulationinsaudiarabiaasinglecenterreview